Melbourne, Australia; 3 April 2019: Starpharma (ASX: SPL, OTCQX: SPHRY) will today present to institutional investors at the Goldman Sachs Tenth Annual Emerging Companies Conference in Sydney.

The invitation-only Goldman Sachs Conference brings together around 40 ASX listed companies over a two-day event with approximately 100 investors ranging from specialist small and mid-cap, to large-cap funds, including a number of offshore investors.

During the conference Starpharma’s Chief Executive Officer, Dr Jackie Fairley, will be presenting the attached slides and this presentation will also be made available on the Starpharma website at www.starpharma.com.

Download ASX Announcement: Starpharma Investor Presentation to Goldman Sachs Conference (PDF 3.7MB)